Changing focus in diabetes: From glucose to CV risk management
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Targeting SGLT2 in Clinical Cardiology: Exploring the Benefits in CV risk, Diabetes & Heart FailureSGLT2 inhibition in cardiology: What is the profile of benefit?
Nikolaus Marx, MD
